U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Microphallus

MedGen UID:
66816
Concept ID:
C0240701
Finding
Synonym: Small penis
SNOMED CT: Small penis (276333003); Reduced size of penis (276333003); Microphallus (276333003)
 
HPO: HP:0030260

Definition

Length of penis more than 2 SD below the mean for age accompanied by hypospadias. [from HPO]

Conditions with this feature

3 beta-Hydroxysteroid dehydrogenase deficiency
MedGen UID:
452446
Concept ID:
C0342471
Disease or Syndrome
Classic 3-beta-hydroxysteroid dehydrogenase deficiency is an autosomal recessive form of CAH characterized by a severe impairment of steroid biosynthesis in both the adrenals and the gonads, resulting in decreased excretion of cortisol and aldosterone and of progesterone, androgens, and estrogens by these tissues. Affected newborns exhibit signs and symptoms of glucocorticoid and mineralocorticoid deficiencies, which may be fatal if not diagnosed and treated early, especially in the severe salt-wasting form. Moreover, male newborns exhibit pseudohermaphroditism with incomplete masculinization of the external genitalia due to an impairment of androgen biosynthesis in the testis. In contrast, affected females exhibit normal sexual differentiation or partial virilization (summary by Rheaume et al., 1992).
X-linked intellectual disability-short stature-overweight syndrome
MedGen UID:
901885
Concept ID:
C0796218
Disease or Syndrome
Kumar-type X-linked syndromic intellectual developmental disorder (MRXSK) is an X-linked recessive disorder that shows phenotypic variability and multisystem involvement apparent from birth or early infancy. Most affected individuals are male, although 1 severely affected girl with a de novo THOC2 mutation has been reported. At the severe end of the spectrum, affected individuals have hypotonia, neonatal difficulties, failure to thrive with poor overall growth, feeding difficulties, respiratory insufficiency, visual impairment, profoundly impaired intellectual development with poor or absent speech, and motor abnormalities, such as inability to walk and hyperkinetic movements. Less severely affected individuals have mildly to moderately impaired intellectual development and speech delay. Additional features include behavioral abnormalities, hearing or visual defects, seizures, dysmorphic facial features, and brain imaging abnormalities (Kumar et al., 2015; Kumar et al., 2018; Kumar et al., 2020).
X-linked intellectual disability-cerebellar hypoplasia syndrome
MedGen UID:
336920
Concept ID:
C1845366
Disease or Syndrome
X-linked intellectual deficit-cerebellar hypoplasia, also known as OPHN1 syndrome, is a rare syndromic form of cerebellar dysgenesis characterized by moderate to severe intellectual deficit and cerebellar abnormalities.
Endocrine-cerebro-osteodysplasia syndrome
MedGen UID:
390740
Concept ID:
C2675227
Disease or Syndrome
Endocrine-cerebro-osteodysplasia (ECO) syndrome is characterized by various anomalies of the endocrine, cerebral, and skeletal systems resulting in neonatal mortality.
Fanconi anemia complementation group F
MedGen UID:
854016
Concept ID:
C3469526
Disease or Syndrome
Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.
Hypogonadotropic hypogonadism 11 with or without anosmia
MedGen UID:
766758
Concept ID:
C3553844
Disease or Syndrome
Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., <4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.
Testicular anomalies with or without congenital heart disease
MedGen UID:
816188
Concept ID:
C3809858
Disease or Syndrome
MIRAGE syndrome
MedGen UID:
924576
Concept ID:
C4284088
Disease or Syndrome
MIRAGE syndrome is an acronym for the major findings of myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy. Cytopenias are typically seen soon after birth; thrombocytopenia is the most common followed by anemia and pancytopenia. Recurrent infections from early infancy include pneumonia, urinary tract infection, gastroenteritis, meningitis, otitis media, dermatitis, subcutaneous abscess, and sepsis. Reported genital phenotypes in those with 46,XY karyotype included hypospadias, microphallus, bifid shawl scrotum, ambiguous genitalia, or complete female genitalia. Hypoplastic or dysgenetic ovaries have been reported in females. Gastrointestinal complications include chronic diarrhea and esophageal dysfunction. Moderate-to-severe developmental delay is reported in most affected individuals. Autonomic dysfunction and renal dysfunction are also reported.
SIN3A-related intellectual disability syndrome due to a point mutation
MedGen UID:
934771
Concept ID:
C4310804
Disease or Syndrome
Witteveen-Kolk syndrome (WITKOS) is an autosomal dominant disorder with characteristic distinctive facial features, microcephaly, short stature, and mildly impaired intellectual development with delayed cognitive and motor development and subtle anomalies on MRI-brain imaging (summary by Balasubramanian et al., 2021).
Developmental delay with or without dysmorphic facies and autism
MedGen UID:
1679263
Concept ID:
C5193106
Disease or Syndrome
Developmental delay with or without dysmorphic facies and autism (DEDDFA) is a complex neurodevelopmental disorder apparent from infancy or early childhood and associated with variably impaired intellectual development. Some patients may be severely affected with no speech and inability to walk, whereas others may be able to attend special schools or have normal intellectual function associated with autism spectrum disorder and mild speech delay. Genetic analysis has suggested that the phenotype can be broadly categorized into 2 main groups. Patients with TRRAP mutations affecting residues 1031-1159 have a more severe disorder, often with multisystem involvement, including renal, cardiac, and genitourinary systems, as well as structural brain abnormalities. Patients with mutations outside of that region tend to have a less severe phenotype with a higher incidence of autism and usually no systemic involvement. Patients in both groups usually have somewhat similar dysmorphic facial features, such as upslanting palpebral fissures, hypertelorism, low-set ears, and broad or depressed nasal bridge, although these features are highly variable (summary by Cogne et al., 2019).

Professional guidelines

PubMed

Gui B, Song Y, Su Z, Luo FH, Chen L, Wang X, Chen R, Yang Y, Wang J, Zhao X, Fan L, Liu X, Wang Y, Chen S, Gong C
J Med Genet 2019 Oct;56(10):685-692. Epub 2019 Jun 11 doi: 10.1136/jmedgenet-2018-105915. PMID: 31186340
Misra M, MacLaughlin DT, Donahoe PK, Lee MM
J Clin Endocrinol Metab 2002 Aug;87(8):3598-602. doi: 10.1210/jcem.87.8.8742. PMID: 12161481
Hinman F Jr
J Urol 1972 Mar;107(3):499-505. doi: 10.1016/s0022-5347(17)61063-2. PMID: 4400892

Recent clinical studies

Etiology

Taghavi K, O'Hagan LA, Hewitt JK, Mouriquand P
J Paediatr Child Health 2022 Sep;58(9):1508-1519. Epub 2022 Jul 6 doi: 10.1111/jpc.16087. PMID: 35791898Free PMC Article
Labanca T, Mañero I, Pannunzio M
Int J Gynecol Cancer 2020 Dec;30(12):1990-1996. Epub 2020 Oct 27 doi: 10.1136/ijgc-2020-001860. PMID: 33109526
Chai JY, Jung BK
Acta Trop 2020 Jan;201:105210. Epub 2019 Oct 7 doi: 10.1016/j.actatropica.2019.105210. PMID: 31600520
Fennoy I
Acta Paediatr 2011 Jun;100(6):846-50. Epub 2011 Mar 7 doi: 10.1111/j.1651-2227.2011.02184.x. PMID: 21284716
Allen TD
Trans Am Assoc Genitourin Surg 1978;70:38-41. PMID: 37629

Diagnosis

Labanca T, Mañero I, Pannunzio M
Int J Gynecol Cancer 2020 Dec;30(12):1990-1996. Epub 2020 Oct 27 doi: 10.1136/ijgc-2020-001860. PMID: 33109526
Zhang DL, Blair MP, Zeid JL, Basith SST, Shapiro MJ
Ophthalmic Genet 2019 Oct;40(5):449-452. doi: 10.1080/13816810.2019.1660380. PMID: 31755341
Finsterer J, Soraru G
J Mol Neurosci 2016 Mar;58(3):321-9. Epub 2015 Oct 19 doi: 10.1007/s12031-015-0663-x. PMID: 26482145
Geffner ME
Cancer Control 2002 May-Jun;9(3):212-22. doi: 10.1177/107327480200900304. PMID: 12060819
Goldenberg JD, Holinger LD, Bressler FJ, Hutchinson LR
Ann Otol Rhinol Laryngol 1996 Feb;105(2):155-7. doi: 10.1177/000348949610500211. PMID: 8659937

Therapy

Taghavi K, O'Hagan LA, Hewitt JK, Mouriquand P
J Paediatr Child Health 2022 Sep;58(9):1508-1519. Epub 2022 Jul 6 doi: 10.1111/jpc.16087. PMID: 35791898Free PMC Article
Fennoy I
Acta Paediatr 2011 Jun;100(6):846-50. Epub 2011 Mar 7 doi: 10.1111/j.1651-2227.2011.02184.x. PMID: 21284716
Swerdloff RS, Wang C
Baillieres Clin Endocrinol Metab 1998 Oct;12(3):501-6. doi: 10.1016/s0950-351x(98)80267-x. PMID: 10332569
Choi SK, Han SW, Kim DH, de Lignieres B
J Urol 1993 Aug;150(2 Pt 2):657-60. doi: 10.1016/s0022-5347(17)35576-3. PMID: 8326617
Allen TD
Trans Am Assoc Genitourin Surg 1978;70:38-41. PMID: 37629

Prognosis

Taghavi K, O'Hagan LA, Hewitt JK, Mouriquand P
J Paediatr Child Health 2022 Sep;58(9):1508-1519. Epub 2022 Jul 6 doi: 10.1111/jpc.16087. PMID: 35791898Free PMC Article
Zhang DL, Blair MP, Zeid JL, Basith SST, Shapiro MJ
Ophthalmic Genet 2019 Oct;40(5):449-452. doi: 10.1080/13816810.2019.1660380. PMID: 31755341
Fujisawa Y, Fukami M, Hasegawa T, Uematsu A, Muroya K, Ogata T
Endocr J 2016 Sep 30;63(9):835-839. Epub 2016 Jul 6 doi: 10.1507/endocrj.EJ16-0143. PMID: 27383042
Hage JJ
Plast Reconstr Surg 1996 Jan;97(1):161-7. doi: 10.1097/00006534-199601000-00026. PMID: 8532774
Burstein S, Grumbach MM, Kaplan SL
Lancet 1979 Nov 10;2(8150):983-6. doi: 10.1016/s0140-6736(79)92560-1. PMID: 91775

Clinical prediction guides

Yeste D, Aguilar-Riera C, Canestrino G, Fernández-Alvarez P, Clemente M, Camats-Tarruella N
Front Endocrinol (Lausanne) 2022;13:884107. Epub 2022 Jun 28 doi: 10.3389/fendo.2022.884107. PMID: 35837313Free PMC Article
Liu Q, Yin X, Li P
Endocr Pract 2022 Sep;28(9):859-866. Epub 2022 Jun 11 doi: 10.1016/j.eprac.2022.06.002. PMID: 35700942
Bernabé KJ, Nokoff NJ, Galan D, Felsen D, Aston CE, Austin P, Baskin L, Chan YM, Cheng EY, Diamond DA, Ellens R, Fried A, Greenfield S, Kolon T, Kropp B, Lakshmanan Y, Meyer S, Meyer T, Delozier AM, Mullins LL, Palmer B, Paradis A, Reddy P, Reyes KJS, Schulte M, Swartz JM, Yerkes E, Wolfe-Christensen C, Wisniewski AB, Poppas DP
J Pediatr Urol 2018 Apr;14(2):157.e1-157.e8. Epub 2018 Feb 2 doi: 10.1016/j.jpurol.2017.11.019. PMID: 29398588Free PMC Article
Aguiar-Oliveira MH, Souza AHO, Oliveira CRP, Campos VC, Oliveira-Neto LA, Salvatori R
Eur J Endocrinol 2017 Aug;177(2):R85-R97. Epub 2017 Apr 20 doi: 10.1530/EJE-16-1047. PMID: 28428227
Arrigo T, Wasniewska M, De Luca F, Valenzise M, Lombardo F, Vivenza D, Vaccaro T, Coradi E, Biason-Lauber A
J Endocrinol Invest 2006 Mar;29(3):208-13. doi: 10.1007/BF03345541. PMID: 16682832

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...